These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22281155)

  • 1. Adjuvant therapy options following curative treatment of hepatocellular carcinoma: a systematic review of randomized trials.
    Zhong JH; Li H; Li LQ; You XM; Zhang Y; Zhao YN; Liu JY; Xiang BD; Wu GB
    Eur J Surg Oncol; 2012 Apr; 38(4):286-95. PubMed ID: 22281155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative therapy options for hepatocellular carcinoma.
    Zhong JH; Ma L; Li LQ
    Scand J Gastroenterol; 2014 Jun; 49(6):649-61. PubMed ID: 24716523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis of adjuvant i(131) lipiodol after excision of hepatocellular carcinoma.
    Furtado R; Crawford M; Sandroussi C
    Ann Surg Oncol; 2014 Aug; 21(8):2700-7. PubMed ID: 24743904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative use of the chemopreventive vitamin K2 analog in patients with hepatocellular carcinoma.
    Zhong JH; Mo XS; Xiang BD; Yuan WP; Jiang JF; Xie GS; Li LQ
    PLoS One; 2013; 8(3):e58082. PubMed ID: 23505456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of interferon alpha treatment on recurrence and survival after complete resection or ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
    Zhang CH; Xu GL; Jia WD; Ge YS
    Int J Cancer; 2009 Jun; 124(12):2982-8. PubMed ID: 19296539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection.
    Chen LT; Chen MF; Li LA; Lee PH; Jeng LB; Lin DY; Wu CC; Mok KT; Chen CL; Lee WC; Chau GY; Chen YS; Lui WY; Hsiao CF; Whang-Peng J; Chen PJ;
    Ann Surg; 2012 Jan; 255(1):8-17. PubMed ID: 22104564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of vitamin K2 in preventing the recurrence of hepatocellular carcinoma after curative treatment: a meta-analysis of randomized controlled trials.
    Riaz IB; Riaz H; Riaz T; Rahman S; Amir M; Badshah MB; Kazi AN
    BMC Gastroenterol; 2012 Nov; 12():170. PubMed ID: 23191943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.
    Zhong JH; Ma L; Wu LC; Zhao W; Yuan WP; Wu FX; Zhang ZM; Huang S; You XM; Li LQ
    Int J Clin Pract; 2012 Jan; 66(1):21-7. PubMed ID: 22171902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma.
    Wang J; He XD; Yao N; Liang WJ; Zhang YC
    Can J Gastroenterol; 2013 Jun; 27(6):351-63. PubMed ID: 23781519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis.
    Zhu GQ; Shi KQ; Yu HJ; He SY; Braddock M; Zhou MT; Chen YP; Zheng MH
    Oncotarget; 2015 Jul; 6(20):18151-61. PubMed ID: 26061709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma.
    Tiong L; Maddern GJ
    Br J Surg; 2011 Sep; 98(9):1210-24. PubMed ID: 21766289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis.
    Xu J; Li J; Chen J; Liu ZJ
    Adv Clin Exp Med; 2015; 24(2):331-40. PubMed ID: 25931368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant systemic drug therapy and recurrence of hepatocellular carcinoma following curative resection.
    Zhong Y; Liu B; Deng M; Xu R
    Drug Discov Ther; 2013 Aug; 7(4):164-6. PubMed ID: 24071579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial.
    Xia Y; Qiu Y; Li J; Shi L; Wang K; Xi T; Shen F; Yan Z; Wu M
    Ann Surg Oncol; 2010 Dec; 17(12):3137-44. PubMed ID: 20602260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis.
    Breitenstein S; Dimitroulis D; Petrowsky H; Puhan MA; Müllhaupt B; Clavien PA
    Br J Surg; 2009 Sep; 96(9):975-81. PubMed ID: 19672926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma.
    Mathurin P; Raynard B; Dharancy S; Kirzin S; Fallik D; Pruvot FR; Roumilhac D; Canva V; Paris JC; Chaput JC; Naveau S
    Aliment Pharmacol Ther; 2003 May; 17(10):1247-61. PubMed ID: 12755838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A systematic review and meta-analysis of randomized controlled trails : adjuvant interferon therapy for hepatocellular carcinoma].
    Zhuang LP; Zeng XT; Meng ZQ
    Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):363-7. PubMed ID: 22971282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis.
    Liao M; Zhu Z; Wang H; Huang J
    Scand J Gastroenterol; 2017; 52(6-7):624-634. PubMed ID: 28276833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harms and benefits of adoptive immunotherapy for postoperative hepatocellular carcinoma: an updated review.
    Yuan BH; Li RH; Yuan WP; Yang T; Tong TJ; Peng NF; Li LQ; Zhong JH
    Oncotarget; 2017 Mar; 8(11):18537-18549. PubMed ID: 28061472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative adjuvant locoregional chemotherapy in patients with hepatocellular carcinoma.
    Izumi R; Shimizu K; Miyazaki I
    Hepatogastroenterology; 1996; 43(12):1415-20. PubMed ID: 8975941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.